PR Newswire

Cision is a leading global provider of earned media software. Cision PR Newswire empowers communicators to identify influencers, craft campaigns and attribute value from the broadest spectrum of media sources, allowing them to create meaningful stories and measure the impact.
Results: 5629-5640 of 44942

Laboratoires Pierre Fabre receives European Commission Approval for BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for the first-line treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer (mCRC)



